Program

Thursday May 28th

11.30 – 12.30:  Arrival, registration and lunch ((Demant/Oticon hall))

Session 1: Genome editing & Gene Therapy (Chair Sine Reker Hadrup)

12.30 - 13.15:   Waseem Qasim, UCL, UK
                         Title: Universal T cells for ALL

13.15 - 14.00:   Saar Gill, UPenn, Philadelphia, US
                         Title: Long-term persistence of CART cells

14.00 - 14.15:   Flash talk (abstract no. 7): Joel Emanuel Sohlin

14.15 - 14.30:   Flash talk (abstract no. 23): Mar Guaza Lasheras 

14.30 - 15.00:   Coffee break (Demant/Oticon hall)


Session 2:        Improving T cell function (Chair Maria Ormhøj)

15.00 - 15.45:   Albane Simon, Gustave Roussy Institute, France
 Title: Restraining T cell differentiation for resistance to exhaustion
                          
15.45 - 16.30:   Sonia Guedan, Hospital Clínic de Barcelona, Spain
                         Title: Engineering CAR-T Cell Fitness: Strategies to Enhance Persistence and Function 

16.30 - 16.45:   Flash talk (abstract no. 4): Marta Velasco Santiago

16.45 - 17.00:   Flash talk (abstract  no. 2): Ladina Hörtensteiner: 

17.00 - 18.30:   POSTER PRESENTATIONS (Demant/Oticon hall),  Drinks by the poster area

19.00-:  Speaker’s dinner (Speakers and CATC)

Friday May 29th

08.00 - 08.30: Refreshments and coffee (Demant/Oticon hall)

Session 3:     Tumor Infiltrating Lymphocytes and beyond (Chair Özcan Met)

08.30 - 9.15:   Michal Besser, Tel Aviv University, Israel
       Title: TIL Therapy: Strategies and Directions

09.15 - 10.00: Alena Gros, VHIO, Barcelona, Spain

       Title: Personalized T-cell Therapies for the Treatment of Solid Cancers

10.00 - 10.15: Flash talk (abstract no. 43): Arianna Draghi

10.15 - 10.30: Flash talk (abstract no. 14): Amalie Kai Bentzen

10.30 - 11.00: Coffee break (Demant/Oticon hall)

Session 4:      Modulation of T cell recognition (Chair Sine Reker Hadrup)

11.00 - 11.45:  Andrew Sewell, University of Cardiff, UK

                       Title: T-cell therapy for cancer

11.45 - 12.30: Kristoffer Haurum Johansen, Technical University of Denmark

                       Title: AI-generation of de novo pMHC binders to target cancer

12.30 - 13.15: Lunch (Demant/Oticon hall)

Session 5:      Modulating immune function (Chair Maria Ormhøj & Özcan Met)

13.15 - 14.00: Di Yu , Uppsala University, Sweden

                       Title: Arming CAR-T cells to induce bystander immunity and advance the therapy of solid tumors

14.00 - 14.45: Filipe Pereira, Lund University, Sweden

                       Title: Cellular Reprogramming for Cancer Immunotherapy

14.45 - 15.30: Tiago da Silva Medina, University of Southern Denmark

                       Title: Overcoming CAR-T cell limitations via epigenetic therapy

15.30 - 16.00: Flash talk award, poster award and closing remarks